Theratechnologies Precio/Valor contable
¿Qué es el Precio/Valor contable de Theratechnologies?
El Precio/Valor contable de Theratechnologies Inc. es 7.84
¿Cuál es la definición de Precio/Valor contable?
El ratio precio-valor contable representa la relación entre el valor de las acciones de una empresa y el valor contable por acción.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Precio/Valor contable de compañías en Sector Health Care en NASDAQ en comparadas con Theratechnologies
¿Qué hace Theratechnologies?
theratechnologies inc., a biopharmaceutical company, markets prescription products in the united states, europe, and canada. it offers egrifta and egrifta sv, for the reduction of excess abdominal fat in human immunodeficiency virus (hiv)-infected patients with lipodystrophy; and trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant hiv-1 infected patients. the company's pipeline products include f8 formulation that could be used for the treatment of hiv-associated lipodystrophy; th-1902 for the treatment of triple negative breast cancer; and th-1904 for the treatment of ovarian cancer. the company was founded in 1993 and is headquartered in montreal, canada.
Empresas con precio/valor contable similar a Theratechnologies
- Eminent Gold tiene Precio/Valor contable de 7.83
- Compania de Distribucion Integral Logista S.A tiene Precio/Valor contable de 7.83
- SML Isuzu tiene Precio/Valor contable de 7.83
- Varian Medical Systems tiene Precio/Valor contable de 7.84
- Eagle Mountain Mining tiene Precio/Valor contable de 7.84
- Wisetech Global tiene Precio/Valor contable de 7.84
- Theratechnologies tiene Precio/Valor contable de 7.84
- Gran Tierra tiene Precio/Valor contable de 7.84
- China Baofeng (International) tiene Precio/Valor contable de 7.84
- Koolearn Technology tiene Precio/Valor contable de 7.84
- eXp World Inc tiene Precio/Valor contable de 7.85
- Firstsource Solutions tiene Precio/Valor contable de 7.85
- Rimbaco Grp Global Ltd tiene Precio/Valor contable de 7.85